Background: Medicinal plants remain an integral part of the lives of people in rural areas. The aim of this study was to document information about the medicinal plants used by Shangaan people in villages under Jongilanga tribal council, Bushbuckridge municipality, Mpumalanga Province, South Africa. Materials and Methods: An ethnobotanical survey of medicinal plants was conducted using a semi-structured questionnaire with 15 traditional healers as informants; one of them also served as a field guide during data collection. Results were analysed by using various quantitative indices of information consensus factor (ICF), use report (UR), frequency citation (FC) and relative frequency citation (RFC). Results and Methods: The study reported 86 medicinal plants used in villages for the treatment of various ailments, the majority (25 species) of which were used for urino-genital disorders. The Fabaceae family was the most represented family (17 species) of all the medicinal plants recorded in this study. The roots were the most frequently used plant part, accounting for 56% of the plants reported, and decoctions were often used in the preparation of herbal remedies. Respiratory diseases had the highest ICF value recorded among the 8 categories of ailments. The highest use report was reported for Combretum collinum (4), while the FC and RFC values (15) were highest in 12 plant species. The study revealed that medicinal plants are still widely used in rural areas and this documentation can serve as an ethno pharmacological basis for selecting plants with potential pharmaceutical properties.
The phytochemical investigation of an ethanol extract ofArtemisia afraled to the isolation of six known compounds, acacetin(1), 12α,4α-dihydroxybishopsolicepolide(2), scopoletin(3),α-amyrin(4), phytol(5), and a pentacyclic triterpenoid betulinic acid(6). The compounds were evaluated for antimicrobial activity against Gram positive (Actinomyces naeslundii, Actinomyces israelii,andStreptococcus mutans), Gram negative bacteria (Prevotella intermedia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitanspreviously known asActinobacillus actinomycetemcomitans), andCandida albicans. The crude extract ofA. afrainhibited the growth of all tested microbial species at concentration range of 1.6 mg/mL to 25 mg/mL. The compounds 1–6 also showed activity range at 1.0 mg/mL to 0.25 mg/mL. Three best compounds (scopoletin, betulinic acid, and acacetin) which showed good antimicrobial activity were selected for further studies. Cytotoxicity of extract and compounds was determined using the XTT cell proliferation kit. The antioxidant activity of the extract and compounds was done using the DPPH scavenging method. The extract showed good antioxidant activity with an IC50value of 22.2 μg/mL. Scopoletin had a strong transformation of the DPPH radical into its reduced form, with an IC50value of 1.24 μg/mL which was significant to that of vitamin C (1.22 μg/mL). Acacetin and betulinic acid exhibited a decreased scavenging activity with the IC50of 2.39 and 2.42 μg/mL, respectively. The extract and compounds showed moderate toxicity on McCoy fibroblast cell line and scopoletin was relatively nontoxic with an IC50value of 132.5 μg/mL. Acacetin and betulinic acid also showed a smooth trend of non-toxic effects with IC50values of 35.44 and 30.96 μg/mL. The obtained results in this study confirm the use ofA. afrain the treatment of microbial infections.
The methanol extract from the stem bark of Terminalia superba (TSB), fractions (TSB1–7) and two compounds isolated following bio-assay guided fractionation namely 3,4′-di-O-methylellagic acid 3′-O-β-d-xylopyranoside (1) and 4′-O-galloy-3,3′-di-O-methylellagic acid 4-O-β-d-xylopyranoside (2) were evaluated for their antimycobacterial, antibacterial and antifungal activities. The broth microdilution, the microplate Alamar Blue assay (MABA) and the agar disc diffusion methods were used for the investigations. The results of the antimycobacterial assays showed that the crude extract, fractions TSB5–7 and compound 1 were able to prevent the growth of all the studied mycobacteria. The lowest minimal inhibitory concentration (MIC) value of 39.06µg/ml for this extract was recorded on both M. smegmatis and M. tuberculosis MTCS2. The corresponding values were 19.53µg/ml and 4.88µg/ml for fractions and compounds respectively. The MIC determination results on other organisms indicated values ranging from 19.53 to 78.12µg/ml for TSB and compound 2 on 90.9% of the tested organisms, meanwhile compound 1 as well as fractions TSB 6 and 7 exhibited detectable MIC values on all studied microorganisms. The overall results provide promising baseline information for the potential use of the crude extract from T. superba, fractions 6–7 and the tested compounds in the treatment of tuberculosis, bacterial and fungal infections